Mount Sinai Hospital is a prominent hospital located in New York City, renowned for its high-quality patient care, extensive research activities, and robust educational programs. Established in 1852, it originally served immigrants and has since evolved into one of the leading healthcare institutions in the United States. The hospital is part of the Mount Sinai Health System, which includes several hospital campuses and a large network of outpatient facilities across New York City. Mount Sinai Hospital is particularly noted for its advancements in areas such as cardiology, cancer treatment, gastroenterology, and neurology. Additionally, it serves as a major teaching hospital, affiliated with the Icahn School of Medicine at Mount Sinai, one of the top medical schools in the country, where it integrates innovative research and clinical care.
Researchers have discovered a neurodevelopmental disorder linked to mutations in the RNU4-2 gene, a non-coding gene, which could impact tens of thousands globally. This finding…
Mount Sinai researchers, in collaboration with scientists at Rockefeller University, have discovered how cocaine and morphine hijack the brain’s natural reward systems. Their study, published…
Research reveals its limitations in medical coding. Researchers at the Icahn School of Medicine at Mount Sinai have found that state-of-the-art artificial intelligence systems, specifically…
High-risk heart patients show improved outcomes and reduced bleeding by over 50% when aspirin is withdrawn one month after PCI, with ticagrelor treatment alone, according…
Researchers unveil how the self-killing activity of bacteria can be harnessed in the fight against antibiotic resistance. Scientists at the Icahn School of Medicine at…
Study sheds light on TAAR1, pointing to potential enhancement opportunities in drug development. Researchers at the Icahn School of Medicine at Mount Sinai have uncovered…
Genomic ‘Tweezer’ Ushers In a New Era of Precision in Microbiome Research Innovative method holds the potential to reshape our understanding of bacteria’s role in…
Statistical technique enhances genetic disease prediction in non-European populations, addressing healthcare equity. A team of scientists from Icahn School of Medicine at Mount Sinai has…
A Mount Sinai study found that blocking an allergy pathway boosts antitumor immunity in lung cancer, with an allergy drug, dupilumab, enhancing the effectiveness of…
Researchers have revealed how the protein TIMP2 regulates brain plasticity, particularly in the hippocampus, offering new insights into treating age-related disorders like Alzheimer’s by targeting…
Harnessing the power of explainable AI, researchers have unveiled the first insights into the complex workings of deep-brain stimulation therapy for treatment-resistant depression. A team…
A recent study from the Icahn School of Medicine at Mount Sinai suggests that fasting could negatively affect immune cells, potentially increasing the risk of…
Dr. Eimear Kenny, a renowned professor of Medicine, Genetics, and Genomic Sciences at the Icahn School of Medicine at Mount Sinai, has made substantial contributions…
Mount Sinai’s AI model, HeartBEiT, improves the accuracy and detail of ECG diagnoses, even for rare conditions with limited data. It interprets ECGs as language…
Wearable devices may be a means to monitor psychological states through effortless data collection using artificial intelligence. Researchers at Mount Sinai have shown that data…
Researchers at Mount Sinai have created a computational method that enables the identification of previously unknown genetic causes for primary lymphedema, thoracic aortic aneurysm disease,…
First U.S. study to show lower cardiac risk of cardiac events in patients following SARS-CoV-2 infection. Analyzing the most extensive datasets in the United States,…
Findings from novel analytic approach could contribute to discovery of new therapeutic targets for Alzheimer’s disease. Mount Sinai researchers have published a study today (February…